Benchmark maintains its buy rating on MSTR with a price target of $650.

Elon Musk cheated Twitter shareholders by waiting too long to disclose his growing stake in the company, the U.S. Securities ...

Elon Musk is being sued by the U.S. Securities and Exchange Commission, claiming he didn't disclose purchases of Twitter ...

The SEC sued Elon Musk, accusing the X owner of failing to properly disclose his purchases of Twitter stock in 2022.

Medical Properties Trust has performed poorly due to its sale leaseback model and tenant bankruptcies. Check out my analysis ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to ...

The U.S. Securities and Exchange Commission is suing Elon Musk for allegedly failing to properly disclose his purchase of ...

The US Securities and Exchange Commission sued Elon Musk on Tuesday for failing to properly disclose his ownership of X, then ...

Blaize (BZAI) and BurTech Acquisition Corp announced that they expect to complete their previously announced business combination on January 12. The combined company will be named ...

Monopar Therapeutics (NASDAQ:MNPR) filed to sell 882,761 shares of common stock for holders. This prospectus is not an offer to sell. Filing More on Monopar Therapeutics Monopar: Radiopharmaceutical ...

The Securities and Exchange Commission waged another legal battle against Tesla CEO and X owner billionaire Elon Musk, this ...

The SEC said the delay allowed Musk to continue buying Twitter shares at artificially low prices, allowing him to underpay by ...